Pure Global AI
ANVISA registration 80020690421Active

GLYCATED HEMOGLOBIN (HbA1C)

ANVISA Registration Number: 80020690421BIO-RAD LABORATORIOS BRASIL LTDABIO-RAD LABORATORIES, INC.Risk Class II
Verified
Device names
Technical name
GLYCATED HEMOGLOBIN (HbA1C)
View exact technical-name matches →
PT: HEMOGLOBINA GLICADA (HbA1C)
Commercial name
Família Liquichek Diabetes Control
View exact commercial-name matches →
Risk class
Class II
Registration details
Registration Number
80020690421
Process Number
25351149883202210
CNPJ
03188198000177
Company information
Registration Holder
BIO-RAD LABORATORIOS BRASIL LTDA
Manufacturer
BIO-RAD LABORATORIES, INC.
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
Jul 07, 2022
Validity
VIGENTE
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80020690421 and manufactured by BIO-RAD LABORATORIES, INC.. The registration is held by BIO-RAD LABORATORIOS BRASIL LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.